The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...
The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...
Obesity has emerged as one of the most pressing public health challenges globally, affecting over 650 million adults, ...
Obesity continues to plague New Yorkers, affecting almost two out of every three adults in our state. That’s why I’m pushing ...
Richard Saynor sees opportunity in copying cutting-edge medication and extols the merits of being boring. Richard Saynor ...
Our top content from the 100th annual American Heart Association (AHA) Scientific Sessions included exclusive expert insights ...
4d
Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback